(Q34265242)

1 August 2017

1 reference

title

Autoimmune lymphoproliferative syndrome type III, an indefinite disorder (English)

1 reference

autoimmune lymphoproliferative syndrome

1 August 2017

0 references

author name string

van der Werff ten Bosch J

series ordinal

1

1 reference

PubMed ID

11378568

1 August 2017

Otten J

series ordinal

2

1 reference

PubMed ID

11378568

1 August 2017

Thielemans K

series ordinal

3

1 reference

1 August 2017

1 May 2001

1 reference

1 August 2017

1 reference

1 August 2017

41

1 reference

1 August 2017

5-6

1 reference

1 August 2017

501-511

1 reference

Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity

1 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

A novel lymphoproliferative/autoimmune syndrome resembling murine lpr/gld disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

The use of the anti-malaria drug Fansidar (pyrimethamine and sulphadoxine) in the treatment of a patient with autoimmune lymphoproliferative syndrome and Fas deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

The molecular basis for apoptotic defects in patients with CD95 (Fas/Apo-1) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Autoimmune lymphoproliferative syndrome with defective Fas: genotype influences penetrance

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Identification of new Fas mutations in a patient with autoimmune lymphoproliferative syndrome (ALPS) and eosinophilia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Response to steroid therapy in autism secondary to autoimmune lymphoproliferative syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Fas ligand mutation in a patient with systemic lupus erythematosus and lymphoproliferative disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Apoptosis signaling by death receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

In vitro activation of CPP32 and Mch3 by Mch4, a novel human apoptotic cysteine protease containing two FADD-like domains

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death--inducing signaling complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

FLICE is activated by association with the CD95 death-inducing signaling complex (DISC).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Suppression of apoptosis by dominant negative mutants of cyclin-dependent protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Involvement of an ICE-like protease in Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Pro-caspase-3 is a major physiologic target of caspase-8.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Autoimmune lymphoproliferative syndrome, a disorder of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Defective CD95/APO-1/Fas signal complex formation in the human autoimmune lymphoproliferative syndrome, type Ia.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Pathological findings in human autoimmune lymphoproliferative syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Revision of the diagnosis of T-zone lymphoma in the father of a patient with autoimmune lymphoproliferative syndrome type II.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Reversible monoclonal lymphadenopathy in autoimmune lymphoproliferative syndrome with functional FAS (CD95/APO-1) deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Loci predisposing to autoimmunity in MRL-Fas lpr and C57BL/6-Faslpr mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Autoimmunity as a consequence of retrovirus-mediated expression of C-FLIP in lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Inhibition of death receptor signals by cellular FLIP

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

A potential mechanism of "cross-talk" between the p55 tumor necrosis factor receptor and Fas/APO1: proteins binding to the death domains of the two receptors also bind to each other

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Tumor necrosis factor sustains the generalized lymphoproliferative disorder (gld) phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

A membrane-bound Fas decoy receptor expressed by human thymocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

T cell receptor signals enhance susceptibility to Fas-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Selective induction of apoptosis in mature T lymphocytes by variant T cell receptor ligands.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Mitochondrial control of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Bcl-x(L) can inhibit apoptosis in cells that have undergone Fas-induced protease activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

The spectrum of apoptotic defects and clinical manifestations, including systemic lupus erythematosus, in humans with CD95 (Fas/APO-1) mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

The apoptosis-1/Fas protein in human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Dyserythropoiesis associated with a Fas-deficient condition in childhood

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

Fas/Apo1 mutations and autoimmune lymphoproliferative syndrome in a patient with type 2 autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428190109060341

10.3109/10428190109060341

21 January 2018

Identifiers

DOI

1 reference

1 August 2017

1 reference

PubMed ID

11378568